• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

CCE Gynecologic Oncology: Cedars-Sinai -- Selection criteria


Awards and distinctions that make the Cedar-Sinai's Women's Cancer Research Institute a Center of Excellence.

Cedars-Sinai Medical Center
Los Angeles, California

Number of Inpatient Procedures

            Uterine and endometrial procedures            682

            Ovarian and fallopian tube procedures         267     

            Cervical and endocervical procedures         52

            Vulva procedures                                               36

Number of ob/gyn cancer research protocols


Patient Volume

            Number of new patient visits                                   1,166

            Number of returning patient visits                           6,372

Ovarian Cancer Registry

            500 patients

Human Tissue/Tumor Bank and Relational Database

            2,800 samples       

Patient Education Efforts

WCRI participates in education related to most gynecologic cancers including extensive education efforts pertaining to ovarian cancer, use of the human papillomavirus vaccine as a means of cancer prevention, and advocacy of patient participation cancer care.

Evidence of Incorporating Research and Clinical Care

WCRI’s work is based on translational research/medicine – quickly and safely bringing research from bedside to bench and back to bedside, allowing extensive study of all cancer with the goal of discovering breakthroughs that will lead to cancer cures and prevention.

The Gilda Radner Hereditary Cancer Detection Program is one of the largest and most comprehensive programs of its type in the country.

Participation in national therapeutic initiatives

            Department of Defense

            Society of Gynecologic Oncologists

            Gynecologic Cancer Foundation

            Ovarian Cancer Research Fund

National awards and recognition

            Dr. Karlan is the Board of Governors’ Chair in Gynecologic Oncology

            Dr. Karlan received the Early Detection Professorship from the American Cancer Society

            Dr. Karlan received the Gynecologic Cancer Foundation Margaret Greenfield/Carmel Cohen Prize for Excellence in Ovarian Cancer Research

            Dr. Karlan was awarded the Dwyer Award for Excellence from UCLA

            Dr. Karlan received the James Nolan Award from Western Association of Gynecologic Oncologists

            Dr. Karlan was a scholar at Harvard Physician Leadership in Academic Medicine

            Dr. Karlan is cited as one of America’s Top Doctors in Cancer

Research Funding

            NIH/DOD Funding – 40 percent

            Foundations – 35 percent

            Pharmaceutical – 25 percent

Recent Videos